标题/作者	年份
The 2021 WHO classification of tumors of the central nervous system: a summary DN Louis, A Perry, P Wesseling, DJ Brat, IA Cree, D Figarella-Branger, ... Neuro-oncology 23 (8), 1231-1251	2021
Genetic and molecular epidemiology of adult diffuse glioma AM Molinaro, JW Taylor, JK Wiencke, MR Wrensch Nature Reviews Neurology 15 (7), 405-417	2019
cIMPACT‐NOW update 6: new entity and diagnostic principle recommendations of the cIMPACT‐Utrecht meeting on future CNS tumor classification and grading DN Louis, P Wesseling, K Aldape, DJ Brat, D Capper, IA Cree, C Eberhart, ... Brain Pathology 30 (4), 844-856	2020
The rsna-asnr-miccai brats 2021 benchmark on brain tumor segmentation and radiogenomic classification U Baid, S Ghodasara, S Mohan, M Bilello, E Calabrese, E Colak, ... arXiv preprint arXiv:2107.02314	2021
Clinical practice guidelines for the management of adult diffuse gliomas T Jiang, DH Nam, Z Ram, W Poon, J Wang, D Boldbaatar, Y Mao, W Ma, ... Cancer letters 499, 60-72	2021
Molecular pathology of tumors of the central nervous system BW Kristensen, LP Priesterbach-Ackley, JK Petersen, P Wesseling Annals of oncology 30 (8), 1265-1278	2019
Diagnostic, therapeutic, and prognostic implications of the 2021 World Health Organization classification of tumors of the central nervous system S Gritsch, TT Batchelor, LN Gonzalez Castro Cancer 128 (1), 47-58	2022
BRAF mutations and the utility of RAF and MEK inhibitors in primary brain tumors KC Schreck, SA Grossman, CA Pratilas Cancers 11 (9), 1262	2019
Incidence and clinicopathologic features of H3 K27M mutations in adults with radiographically-determined midline gliomas KC Schreck, S Ranjan, N Skorupan, C Bettegowda, CG Eberhart, ... Journal of neuro-oncology 143, 87-93	2019
cIMPACT‐NOW: a practical summary of diagnostic points from Round 1 updates DN Louis, DW Ellison, DJ Brat, K Aldape, D Capper, C Hawkins, ... Brain Pathology 29 (4), 469-472	2019
Automated machine learning based on radiomics features predicts H3 K27M mutation in midline gliomas of the brain X Su, N Chen, H Sun, Y Liu, X Yang, W Wang, S Zhang, Q Tan, J Su, ... Neuro-oncology 22 (3), 393-401	2020
Reconstructing the molecular life history of gliomas FP Barthel, P Wesseling, RGW Verhaak Acta neuropathologica 135, 649-670	2018
Impact of the H3K27M mutation on survival in pediatric high-grade glioma: a systematic review and meta-analysis VM Lu, MA Alvi, KL McDonald, DJ Daniels Journal of Neurosurgery: Pediatrics 23 (3), 308-316	2018
Applications of molecular neuro-oncology-a review of diffuse glioma integrated diagnosis and emerging molecular entities MD Wood, AM Halfpenny, SR Moore Diagnostic pathology 14 (1), 1-16	2019
Grading of adult diffuse gliomas according to the 2021 WHO Classification of Tumors of the Central Nervous System T Komori Laboratory Investigation 102 (2), 126-133	2022
Alternative lengthening of telomeres, ATRX loss and H3‐K27M mutations in histologically defined pilocytic astrocytoma with anaplasia FJ Rodriguez, JA Brosnan‐Cashman, SJ Allen, MA Vizcaino, C Giannini, ... Brain Pathology 29 (1), 126-140	2019
High frequency of H3 K27M mutations in adult midline gliomas A Ebrahimi, M Skardelly, MU Schuhmann, M Ebinger, D Reuss, ... Journal of Cancer Research and Clinical Oncology 145, 839-850	2019
Clinical implications of the 2021 edition of the WHO classification of central nervous system tumours C Horbinski, T Berger, RJ Packer, PY Wen Nature Reviews Neurology 18 (9), 515-529	2022
Contemporary assessment of extent of resection in molecularly defined categories of diffuse low-grade glioma: a volumetric analysis VK Kavouridis, A Boaro, J Dorr, EY Cho, JB Iorgulescu, DA Reardon, ... Journal of neurosurgery 133 (5), 1291-1301	2019
The cIMPACT-NOW updates and their significance to current neuro-oncology practice LN Gonzalez Castro, P Wesseling Neuro-Oncology Practice 8 (1), 4-10	2021

1 - 20

计算机程序会自动估算并确定日期和引用次数。